p27kip1：肿瘤治疗的一个靶点？
p27kip1: a target for tumor therapies?
作者信息
Nickeleit Irina, Zender Steffen, Kossatz Uta, Malek Nisar P
机构信息
Institute for Molecular Biology, Hannover Medical School, Hannover, Germany.
出版信息
Cell Div. 2007 May 9;2:13. doi: 10.1186/1747-1028-2-13.
Abstract
The cyclin kinase inhibitor p27kip1 acts as a potent tumor supressor protein in a variety of human cancers. Its expression levels correlate closely with the overall prognosis of the affected patient and often predict the outcome to different treatment modalities. In contrast to other tumor suppressor proteins p27 expression levels in tumor cells are frequently regulated by ubiquitin dependent proteolysis. Re-expression of p27 in cancer cells therefore does not require gene therapy but can be achieved by interfering with the protein turnover machinery. In this review we will summarize experimental results which highlight the potential use of p27 as a target for oncological therapies.
摘要
细胞周期蛋白激酶抑制剂p27kip1在多种人类癌症中作为一种有效的肿瘤抑制蛋白发挥作用。其表达水平与受影响患者的总体预后密切相关，并且常常能预测不同治疗方式的结果。与其他肿瘤抑制蛋白不同，肿瘤细胞中p27的表达水平常常受到泛素依赖性蛋白水解作用的调控。因此，在癌细胞中重新表达p27不需要基因治疗，而是可以通过干扰蛋白质周转机制来实现。在这篇综述中，我们将总结实验结果，这些结果突出了p27作为肿瘤治疗靶点的潜在用途。
相似文献
1
p27kip1: a target for tumor therapies?p27kip1：肿瘤治疗的一个靶点？
Cell Div. 2007 May 9;2:13. doi: 10.1186/1747-1028-2-13.
2
Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells.p27Kip1抗降解形式的可诱导表达导致乳腺癌细胞生长停滞和凋亡。
FEBS Lett. 2005 Jul 18;579(18):3932-40. doi: 10.1016/j.febslet.2005.06.012.
3
Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1.Pirh2促进细胞周期蛋白依赖性激酶抑制剂p27Kip1的泛素依赖性降解。
Cancer Res. 2007 Nov 15;67(22):10789-95. doi: 10.1158/0008-5472.CAN-07-2033.
4
Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor.套细胞淋巴瘤缺乏细胞周期蛋白依赖性激酶抑制剂p27Kip1的表达。
Am J Pathol. 1998 Jul;153(1):175-82. doi: 10.1016/S0002-9440(10)65558-7.
5
p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers.p27kip1：一种在人类癌症中具有预后意义的多功能细胞周期蛋白依赖性激酶抑制剂。
Am J Pathol. 1999 Feb;154(2):313-23. doi: 10.1016/S0002-9440(10)65277-7.
6
Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.突变型B-RAF信号传导和细胞周期蛋白D1调节人黑素瘤细胞中Cks1/细胞周期蛋白依赖性激酶调节亚基1介导的p27Kip1降解。
Oncogene. 2007 Feb 15;26(7):1056-66. doi: 10.1038/sj.onc.1209861. Epub 2006 Aug 21.
7
p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.p27Kip1表达与晚期上皮性卵巢癌的临床结局相关：多变量分析
Clin Cancer Res. 2000 Dec;6(12):4816-22.
8
How to decrease p27Kip1 levels during tumor development.如何在肿瘤发展过程中降低p27Kip1水平。
Cancer Cell. 2006 Feb;9(2):75-6. doi: 10.1016/j.ccr.2006.01.020.
9
The role of cyclin-dependent kinase inhibitor p27Kip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibition.细胞周期蛋白依赖性激酶抑制剂p27Kip1在抗HER2抗体诱导的G1期细胞周期阻滞和肿瘤生长抑制中的作用。
J Biol Chem. 2003 Jun 27;278(26):23441-50. doi: 10.1074/jbc.M300848200. Epub 2003 Apr 16.
10
Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is an indicator of malignant behavior in oral squamous cell carcinoma.细胞周期蛋白依赖性激酶抑制剂p27Kip1表达降低是口腔鳞状细胞癌恶性行为的一个指标。
Cancer. 1998 Dec 15;83(12):2447-55. doi: 10.1002/(sici)1097-0142(19981215)83:12<2447::aid-cncr7>3.0.co;2-a.
引用本文的文献
1
The edible ethanol extract of suppresses colon cancer progression by inhibiting the proliferation-cell signaling-metastasis axis.[提取物名称]的可食用乙醇提取物通过抑制增殖-细胞信号传导-转移轴来抑制结肠癌进展。
Nutr Res Pract. 2025 Feb;19(1):14-29. doi: 10.4162/nrp.2025.19.1.14. Epub 2024 Oct 2.
2
Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors.使用有效的代谢抑制剂靶向前列腺癌细胞中的异常唾液酸化和岩藻糖化。
Glycobiology. 2023 Dec 30;33(12):1155-1171. doi: 10.1093/glycob/cwad085.
3
The Role of Immunohistochemical Markers for the Diagnosis and Prognosis of Adrenocortical Neoplasms.免疫组织化学标志物在肾上腺皮质肿瘤诊断和预后中的作用
J Pers Med. 2021 Mar 15;11(3):208. doi: 10.3390/jpm11030208.
4
Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27.Myc 通过激活 Cdk1 和磷酸化 p27 来刺激细胞周期进程。
Sci Rep. 2019 Dec 10;9(1):18693. doi: 10.1038/s41598-019-54917-1.
5
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways.表皮生长因子受体细胞增殖信号通路
Cancers (Basel). 2017 May 17;9(5):52. doi: 10.3390/cancers9050052.
6
AMPKα2 Regulates Bladder Cancer Growth through SKP2-Mediated Degradation of p27.AMPKα2通过SKP2介导的p27降解调控膀胱癌生长。
Mol Cancer Res. 2016 Dec;14(12):1182-1194. doi: 10.1158/1541-7786.MCR-16-0111. Epub 2016 Sep 16.
7
Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.MDA-9/连环蛋白（SDCBP）作为胶质瘤干细胞存活和干性调节因子的新功能。
Oncotarget. 2016 Aug 23;7(34):54102-54119. doi: 10.18632/oncotarget.10851.
8
Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells.通过诱导多能干细胞中p27过表达减弱畸胎瘤形成
Stem Cell Res Ther. 2016 Feb 15;7:30. doi: 10.1186/s13287-016-0286-3.
9
BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein.BCR-ABL1通过将p27转化为一种细胞质癌蛋白来促进白血病。
Blood. 2014 Nov 20;124(22):3260-73. doi: 10.1182/blood-2013-04-497040. Epub 2014 Oct 7.
10
Nodal signaling promotes a tumorigenic phenotype in human breast cancer.节点信号传导促进人类乳腺癌的致瘤表型。
Semin Cancer Biol. 2014 Dec;29:40-50. doi: 10.1016/j.semcancer.2014.07.007. Epub 2014 Jul 26.
本文引用的文献
1
p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.Src介导的p27磷酸化调节细胞周期蛋白E-Cdk2的抑制作用。
Cell. 2007 Jan 26;128(2):281-94. doi: 10.1016/j.cell.2006.11.049.
2
Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.p27Kip1的细胞周期蛋白依赖性激酶抑制活性和稳定性直接受致癌性酪氨酸激酶调控。
Cell. 2007 Jan 26;128(2):269-80. doi: 10.1016/j.cell.2006.11.047.
3
C-terminal phosphorylation controls the stability and function of p27kip1.C 端磷酸化调控 p27kip1 的稳定性和功能。
EMBO J. 2006 Nov 1;25(21):5159-70. doi: 10.1038/sj.emboj.7601388. Epub 2006 Oct 19.
4
Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.p27Kip1基因的种系突变在大鼠和人类中引发一种多发性内分泌肿瘤综合征。
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15558-63. doi: 10.1073/pnas.0603877103. Epub 2006 Oct 9.
5
Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer.在肺癌和结肠癌小鼠模型中检测SCFskp2途径介导的p27降解的重要性。
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14009-14. doi: 10.1073/pnas.0606316103. Epub 2006 Sep 11.
6
p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex.p27kip1独立促进大脑皮质中的神经元分化和迁移。
Genes Dev. 2006 Jun 1;20(11):1511-24. doi: 10.1101/gad.377106. Epub 2006 May 16.
7
Ubiquitin ligases: cell-cycle control and cancer.泛素连接酶：细胞周期调控与癌症
Nat Rev Cancer. 2006 May;6(5):369-81. doi: 10.1038/nrc1881.
8
Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity.胞质p27（Kip1）的减少会抑制癌细胞的迁移、存活和致瘤性。
Cancer Res. 2006 Feb 15;66(4):2162-72. doi: 10.1158/0008-5472.CAN-05-3304.
9
A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression.静息细胞中一条控制p27Kip1稳定性、亚细胞定位及肿瘤抑制作用的信号通路。
Genes Dev. 2006 Jan 1;20(1):47-64. doi: 10.1101/gad.1384406.
10
Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation.靶向S期激酶相关蛋白2的小分子干扰RNA通过抑制p27降解来抑制口腔癌细胞的生长。
Mol Cancer Ther. 2005 Mar;4(3):471-6. doi: 10.1158/1535-7163.MCT-04-0232.
Zotero 插件